News

Dr. Hongkyun Kim Secures NIH Grant for Groundbreaking Research

Dr. Hongkyun Kim Secures NIH Grant for Groundbreaking Research

Dr. Hongkyun Kim Secures NIH Grant for Groundbreaking Research

A researcher from Rosalind Franklin University (RFU) is making waves in the field of neurological disease research. Dr. Hongkyun Kim, a professor specializing in cell biology and anatomy at RFU, has been awarded a substantial five-year grant from the National Institute of Neurological Disorders and Stroke. The grant, which amounts to $1,911,417, will support Dr. Kim's innovative research on the molecular and cellular regulation of voltage-gated calcium channels, specifically the CaV2 channels.

The Importance of CaV2 Calcium Channels

This research focuses on a significant protein involved in synaptic transmission—the voltage-gated calcium channel. These channels play a crucial role in the communication between nerve cells, determining the strength and effectiveness of synaptic signaling. Understanding how these channels function and identifying any abnormalities is vital, as dysfunction in these channels can lead to a variety of neurological disorders, including epilepsies, migraines, and chronic pain.

Research Insights

Dr. Kim's findings aim to uncover how human proteins become dysregulated and contribute to these disorders. By using C. elegans as a model organism, his team plans to identify the specific molecular components that govern the abundance and function of these essential calcium channels.

“Our favorite protein among those involved in synaptic transmission is the CaV2 voltage-gated calcium channel,” Dr. Kim mentioned. “This channel is vital for neurotransmitter release at neuron synapses, and our goal is to enhance our understanding of its molecular framework.”

Recognition of Expertise

Joseph DiMario, PhD, RFU's executive vice president for research, expressed admiration for Dr. Kim’s extensive body of work in the realm of neurological disorders. He emphasized that this NIH grant not only reinforces Dr. Kim's standing as an expert but also holds promise for expanding knowledge about the critical roles these channels play in disease pathology.

Dr. Kim's Background

Dr. Kim joined the community at RFU in 2008 after completing his post-doctoral training at the Ernest Gallo Clinic and Research Center at UCSF. His research journey has consistently centered on genetic and genomic methods aimed at unraveling the underlying mechanisms that lead to neurological and neuromuscular diseases. This new funding from the NIH represents a significant opportunity for Dr. Kim to further his investigations into calcium channels and their role in neurobiology.

About Rosalind Franklin University

Rosalind Franklin University of Medicine and Science is dedicated to advancing the field of health and biomedical research. With a commitment to interprofessional education, RFU seeks to equip healthcare professionals with the knowledge necessary to improve wellness in the communities they serve. The institution is named after Dr. Rosalind Franklin, who played a pivotal role in the discovery of DNA's structure. RFU conducts research in various areas, including neuroscience, genetic disorders, and metabolic diseases. The university's diverse programs encompass a variety of fields such as nursing, pharmacy, and podiatric medicine.

For any inquiries, the Office of Marketing and Communications is available for contact.

Frequently Asked Questions

What is the focus of Dr. Kim's research?

Dr. Kim's research focuses on the molecular and cellular regulation of voltage-gated calcium channels, particularly in the context of neurological diseases.

Why are CaV2 calcium channels significant?

CaV2 calcium channels are critical for neurotransmitter release and synaptic communication between nerve cells. Abnormalities in these channels can lead to various neurological disorders.

What institution is Dr. Kim affiliated with?

Dr. Kim is a professor at Rosalind Franklin University of Medicine and Science.

How much funding did Dr. Kim receive for his research?

Dr. Kim was awarded a total of $1,911,417 from the National Institute of Neurological Disorders and Stroke.

What impact does this research have?

This research is expected to enhance the understanding of neurological disorders and may lead to new therapeutic approaches by uncovering crucial mechanisms behind synaptic transmission.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 8

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 10

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 5

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 4

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 5

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Rise and Fall of MedMen's Cannabis Empire

Updated Category News Views 178

Let's slice through the smoke and mirrors of MedMen's saga—a story that captures the dizzying heights and staggering lows of what was once the poster child for America's cannabis gold rush. The buzz is about a documentary from Bungalow Media + Entertainment that’s gearing up to pull back the curtain on Adam Bierman and his rollercoaster ride with MedMen. They kicked...

Continue Reading
Draganfly Secures $25 Million for Innovative Drone Solutions

Updated Category News Views 136

Overview of Recent Financial Activities Draganfly Inc. (NASDAQ: DPRO), a leader in drone technology and robotics, has made significant strides in its financial landscape by securing a registered direct offering. This initiative is designed to enhance their operational capabilities and support new product developments. Details of the Direct Offering In a recent...

Continue Reading
Current Sentiment Analysis: Canaan Inc's Short Interest Insights

Updated Category News Views 304

Canaan Inc's Current Short Interest Overview Canaan Inc (NYSE: CAN) is witnessing changes in its stock sentiment, particularly regarding its short interest. Recent reports indicate that the short interest, expressed as a percentage of the float, has dropped by 8.14%. Currently, 36.17 million shares are sold short, representing 8.58% of the total shares available for...

Continue Reading
iHerb's Chief Operating Officer Miriee Chang Set to Retire

Updated Category News Views 196

iHerb Announces Retirement of COO Miriee Chang iHerb, a global leader in online retail for wellness products, has announced the planned retirement of Chief Operating Officer Miriee Chang. This change marks a significant transition for the company, dedicated to maintaining its operational excellence and customer service quality. Continuity During the Transition Miriee...

Continue Reading
Liberty Broadband to Reveal Q4 2024 Performance in Upcoming Call

Updated Category News Views 103

Liberty Broadband Corporation's Upcoming Conference Call Liberty Broadband Corporation (Nasdaq: LBRDA, LBRDK, LBRDP) is gearing up for a significant event as it prepares to hold a conference call to unveil its financial results for the fourth quarter of 2024. This highly anticipated call is set to take place soon, providing an opportunity for stakeholders and interested...

Continue Reading